UniqueMotionGraphics Clinical-stage immuno-oncology company Affimed N.V (NASDAQ:AFMD) received a written notice from the staff of
Affimed N.V. (NASDAQ:AFMD) said on Tuesday that it will file an application for opening of
Affimed (NASDAQ:AFMD) has received a notice from The Nasdaq Stock Market LLC for its failure
Michail_Petrov-96 Shares of Affimed (NASDAQ:AFMD) plunged 23% in early trading Tuesday after the company reported
Affimed N.V. announced data from phase 2 study of the combination of acimtamig with Artiva
Affimed press release (NASDAQ:AFMD): Q3 GAAP EPS of -€0.94. Revenue of €0.16M (-91.8% Y/Y). As
Affimed (NASDAQ:AFMD) is scheduled to announce Q3 earnings results on Thursday, November 14th, before market
Affimed (NASDAQ:AFMD) filed for $20M mixed securities shelf. This preliminary prospectus is not an offer
Affimed press release (NASDAQ:AFMD): Q2 GAAP EPS of -€1.01. Revenue of €0.2M (-85.7% Y/Y). As of
Summary: On 06/11/24, I published an article on Affimed focused on my belief the company’s